Pyrazinamide resistance associated with pncA gene mutation in Mycobacterium tuberculosis in Japan.
Thirty Japanese clinical isolates of Mycobacterium tuberculosis were analysed by pyrazinamide susceptibility testing and pyrazinamidase assay, as well as polymerase chain reaction for single-strand conformational polymorphism and direct sequencing of the gene encoding pyrazinamidase (pncA). All sensitive isolates showed pyrazinamidase activity and a wild-type pncA gene, but three resistant isolates had pncA gene mutations and lacked pyrazinamidase activity. The latter isolates showed a minimum inhibitory concentration of at least 100 mg/l by the 7H10 agar proportion method and 400 mg/l by the 7H9 liquid medium method. Isolate 28 showed T-to-C change at position 11, leading to Leu4 --> Ser substitution; isolate 29 had an 8-bp deletion from position 382; and isolate 30 had A-to-C change at position 29, leading to Gln10 --> Pro substitution. The deletion has not been described previously. This is the first demonstration of pncA gene mutations in PZA-resistant M. tuberculosis strains isolated from Japanese patients.
Endoh
T
T
Division of Laboratory Diagnosis, Sapporo Medical University School of Medicine, Japan.
Yagihashi
A
A
Uehara
N
N
Kobayashi
D
D
Tsuji
N
N
Nakamura
M
M
Hayashi
S
S
Fujii
N
N
Watanabe
N
N
D000581:Amidohydrolases / Q000235:genetics*; D000995:Antitubercular Agents / Q000494:pharmacology*; D004252:DNA Mutational Analysis; D017931:DNA Primers; D004269:DNA, Bacterial / Q000235:genetics*; D004305:Dose-Response Relationship, Drug; D004351:Drug Resistance / Q000235:genetics; D006801:Humans; D007564:Japan; D009169:Mycobacterium tuberculosis / Q000187:drug effects* / Q000235:genetics*; D016133:Polymerase Chain Reaction; D011718:Pyrazinamide / Q000494:pharmacology*
D000995:Antitubercular Agents; D017931:DNA Primers; D004269:DNA, Bacterial; D011718:Pyrazinamide; D000581:Amidohydrolases; C022490:pyrazinamide deamidase